MRI for assessing erosion and joint space narrowing in inflammatory arthropathies

Annals of the New York Academy of Sciences

Volumn 1154, Issue , 2009, Pages 41-51

  Momeni, Mahnaz ^a   Brindle, Kathleen ^a  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Erosion; Joint space narrowing; Magnetic resonance imaging

Indexed keywords

DISEASE MODIFYING ANTIRHEUMATIC DRUG; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

BONE EROSION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; FOLLOW UP; IMAGE ANALYSIS; IMMUNE RESPONSE; JOINT CAVITY; JUVENILE RHEUMATOID ARTHRITIS; MEDICAL ASSESSMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

EID: 60549084727     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2009.04384.x     Document Type: Review

References (46)

1. Goldring, S. 2003. Osteoporosis and rheumatic diseases. In Primer of the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. : 379 382. Lippincott Williams & Wilkins. Philadelphia.
2. Gough, A.K., J. Lilley, S. Eyre, et al. 1994. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 344 : 23 27.
3. Redlich, K., S. Hayer, A. Maier, et al. 2002. Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin. Arthritis Rheum. 46 : 785 792.
4. Redlich, K., S. Hayer, R. Ricci, et al. 2002. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110 : 1419 1427.
5. Schett, G., K. Redlich, S. Hayer, et al. 2003. Osteoprotegerin protects against generalized bone loss in tumor necrosis factor-transgenic mice. Arthritis Rheum. 48 : 2042 2051.
6. Zwerina, J., S. Hayer, M. Tohidast-Akrad, et al. 2004. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: Effects on synovial inflammation, bone erosion, and cartilage destruction. Arthritis Rheum. 50 : 277 290.
7. Anandarajah, A.P. 2006. Anti-RANKL therapy for inflammatory bone disorder: Mechanism and potential clinical applications. J. Cell. Biochem. 97 : 226 232.
8. Takayanagi, H., S. Kim, K. Matsuo, et al. 2002. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 : 744 749.
9. Wyzga, N., S. Varghese, S. Wikel, et al. 2004. Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone 35 : 614 620.
10. Ritchlin, C.T., S.A. Haas-Smith, P. Li, et al. 2003. Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111 : 821 831.
11. Kong, Y.Y., U. Feige, I. Sarosi, et al. 1999. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402 : 304 309.
12. Sato, K. & H. Takayanagi. 2006. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr. Opin. Rheumatol. 18 : 419 426.
13. Kasono, K., K. Sato, Y. Sato, et al. 1993. Inhibitory effect of interleukin-4 on osteoclast-like cell formation in mouse bone marrow culture. Bone Miner. 21 : 179 188.
14. Abu-Amer, Y. 2001. IL-4 abrogates osteoclastogenesis through STAT6-dependent inhibition of NF-κB. J. Clin. Invest. 107 : 1375 1385.
15. Hong, M.H., H. Williams, C.H. Jin, et al. 2000. The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine- phosphorylated proteins. J. Bone Miner. Res. 15 : 911 918.
16. Takahashi, N., G.R. Mundy & G.D. Roodman. 1986. Recombinant human interferon-γ inhibits formation of human osteoclast-like cells. J. Immunol. 137 : 3544 3549.
17. Nanes, M.S. 2003. Tumor necrosis factor-α: Molecular and cellular mechanisms in skeletal pathology. Gene 321 : 1 15.
18. Catrina, A.I., C. Trollmo, E. af Klint, et al. 2005. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: Extended report. Arthritis Rheum. 52 : 61 72.
19. Klarlund, M., M. Østergaard & K.E. Jensen. 2000. Magnetic resonance imaging, radiography, and scintigraphy of the finger joints. Ann. Rheum. Dis. 59 : 521 528.
20. Scheel, A.K. & K.G. Hermann. 2006. Prospective 7 year follow up imaging study comparing radiography, ultrasonography, and magnetic resonance imaging in rheumatoid arthritis finger joints. Ann. Rheum. Dis. 65 : 595 600.
21. Ashikyan, O. 2007. The role of magnetic resonance imaging in the early diagnosis of rheumatoid arthritis. Top. Magn. Reson. Imaging 18 : 169 176.
22. Østergaard, M. & C. Peterfy. 2003. OMERACT rheumatoid arthritis magnetic in resonance imaging studies. J. Rheumatol. 30 : 1385 1386.
23. Tehranzadeh, J., O. Ashikyan, J. Dascalos & C. Dennehey. 2004. MRI of large intraosseous lesions in patients with inflammatory arthritis. AJR Am. J. Roentgenol. 183 : 1453 1456.
24. McQueen, F.M. & N. Benton. 2001. What is the fate of erosions in early rheumatoid arthritis? Ann. Rheum. Dis. 60 : 859 868.
25. Oliver, C. & S. Speake. 1996. Advantages of an increased dose of MRI contrast agent for enhancing inflammatory synovium. Clin. Radiol. 51 : 487 493.
26. Konig, H., J. Sieper & K.J. Wolf. 1990. Rheumatoid arthritis: Evaluation of hypervascular and fibrous pannus with dynamic MR imaging enhanced with Gd-DTPA. Radiology 176 : 473 477.
27. Cimmino, M.A., S. Innocenti, F. Livrone, et al. 2003. Dynamic gadolinium-enhanced magnetic resonance imaging of the wrist in patients with rheumatoid arthritis can discriminate active from inactive disease. Arthritis Rheum. 48 : 1207 1213.
28. Yamato, M., K. Tamai, T. Yamaguchi, et al. 1993. MRI of the knee in rheumatoid arthritis: Gd-DTPA perfusion dynamics. J. Comput. Assist. Tomogr. 17 : 781 785.
29. Sugimoto, H., A. Takeda & K. Hyodoh. 2001. MR imaging for evaluation of early rheumatoid arthritis. Sem. Musculoskeletal Radiol. 5 : 159 165.
30. Zikou, A.K., M.I. Argyropoulou, P.V. Voulgari, et al. 2006. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with adalimumab. J. Rheumatol. 33 : 219 223.
31. Argyropoulou, M.I., A. Glatzouni, P.V. Voulgari, et al. 2005. Magnetic resonance imaging quantification of hand synovitis in patients with rheumatoid arthritis treated with infliximab. Joint Bone Spine 72 : 557 561.
32. Benton, N., N. Stewart, J. Crabbe, et al. 2004. MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years. Ann. Rheum. Dis. 63 : 555 561.
33. McQueen, F., M. Lassere & M. Østergaard. 2006. Magnetic resonance imaging in psoriatic arthritis: A review of the literature. Arthritis Res. Ther. 8 : 207.
34. Ritchlin, C.T., S.A. Haas-Smith, P. Li, D.G. Hicks & E.M. Schwartz. 2003. Mechanisms of TNFα and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis. J. Clin. Invest. 111 : 821 831.
35. Savnik, A., H. Malmskov & H.S. Thomsen. 2002. MRI of the wrist and finger joints in inflammatory joint diseases at 1-year interval: MR features to predict bone erosions. Eur. Radiol. 12 : 1203 1210.
36. Backhaus, M., T. Kamradt & D. Sandrock. 1999. Arthritis of the finger joints. A comprehensive approach comparing conventional radiography, scintigraphy, ultrasound and contrast-enhanced MRI. Arthritis Rheum. 42 : 1232 1234.
37. Bollow, M., T. Fischer, H. Reißhauer & M. Backhaus. 2000. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann. Rheum. Dis. 59 : 135 140.
38. Savnik, A., H. Malmskov & H.S. Thomsen. 2001. Magnetic resonance imaging of the wrist and finger joints in patients with inflammatory joint diseases. J. Rheumatol. 28 : 2193 2200.
39. McQueen, F.M., N. Benton, D. Perry & J. Crabbe. 2003. Bone oedema scored on magnetic resonance scans of the dominant carpus at presentation predicts radiographic joint damage at the hands and feet six years later in patients with rheumatoid arthritis. Arthritis Rheum. 48 : 1814 1827.
40. Giovagnoni, A., W. Grassi & F. Terilli. 1995. MRI of the hand in psoriatic and rheumatical arthritis. Eur. Radiol. 5 : 590 595.
41. Offidani, A., A. Cellini, G. Valeri & A. Giovagnoni. 1998. Subclinical joint involvement in psoriasis: Magnetic resonance imaging and X-ray findings. Acta Derm. Venereol. 78 : 463 465.
42. McQueen, F., M. Østergaard, C. Peterfy, et al. 2005. Pitfalls in scoring MR images of rheumatoid arthritis wrist and metacarpophalangeal joints. Ann. Rheum. Dis. 64 (Suppl. 1 i48 i55.
43. Parodi, M., E. Silvestri, G. Garlaschi, et al. 2006. How normal are the hands of normal controls? A study with dedicated magnetic resonance imaging. Clin. Exp. Rheumatol. 24 : 134 141.
44. Timins, M.E., S.E. O'Connell, S.J. Erickson, et al. 1996. MR imaging of the wrist: Normal findings that may simulate disease. Radiographics 16 : 987 995.
45. Goldring, S.R. & E.M. Gravallese. 2004. Bisphosphonates: Environmental protection for the joint? Arthritis Rheum. 50 : 2044 - 2047.
46. Tam, L.-S., J.F. Griffith, A.B. Yu, et al. 2007. Rapid improvement in rheumatoid arthritis patients on combination of methotrexate and infliximab: Clinical and magnetic resonance imaging evaluation. Clin. Rheumatol. 26 : 941 946.